General practitioners (GPs) may soon be able to identify patients with an increased risk of lung cancer up to four months ...

Dr. Douglas Reznick shares advice for patients with lung or head and neck cancer who may feel overwhelmed by their diagnosis.

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering clinicians' ...

One in 3,000 People at Risk of Punctured Lung ... cancer and shown that these allow immunotherapies to target non-responsive ... Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage ...

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case.

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for ...

For most screenable cancers, a pandemic-related surge of late-stage diagnoses in 2020 quickly returned to pre-pandemic levels in 2021, with the exception of cervical cancer.  According to the National ...

A new report on cancer in the U.S. shows a steady decline in overall deaths from 2001 through 2022. The rate of diagnoses among men fell from 2001 through 2013 and then stabilized through 2021, but ...

Previous estimates had put this risk closer to ... Rates of Breast and Colorectal Cancer Screening Nearly Four-Fold Higher Than Lung Cancer Screening Among Those Eligible Apr. 2, 2025 — Lung ...

this time focusing on patients with earlier-stage non-small cell lung cancer (NSCLC). The new study – called INTerpath-009 – is the third late-stage trial of the combination and will explore ...